YAP immunoreactivity is directly related to pilomatrixoma size and proliferation rate
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
YAP immunoreactivity is directly related to pilomatrixoma size and proliferation rate
Authors
Keywords
YAP, TAZ, Pilomatrixoma, Skin
Journal
ARCHIVES OF DERMATOLOGICAL RESEARCH
Volume 307, Issue 4, Pages 379-383
Publisher
Springer Nature
Online
2014-12-17
DOI
10.1007/s00403-014-1530-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elevated YAP and Its Downstream Targets CCN1 and CCN2 in Basal Cell Carcinoma
- (2014) Taihao Quan et al. AMERICAN JOURNAL OF PATHOLOGY
- Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions
- (2014) Rocco Cappellesso et al. CANCER CYTOPATHOLOGY
- YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response
- (2014) Luca Azzolin et al. CELL
- The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
- (2014) X. Varelas DEVELOPMENT
- Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis
- (2014) A. N. Lau et al. EMBO JOURNAL
- Molecular Pathways: YAP and TAZ Take Center Stage in Organ Growth and Tumorigenesis
- (2013) S. Piccolo et al. CLINICAL CANCER RESEARCH
- Hippo pathway effector Yap promotes cardiac regeneration
- (2013) Mei Xin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Yap- and Cdc42-Dependent Nephrogenesis and Morphogenesis during Mouse Kidney Development
- (2013) Antoine Reginensi et al. PLoS Genetics
- Survivin expression impacts prognostically on NSCLC but not SCLC
- (2012) Antonio Rosato et al. LUNG CANCER
- YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy
- (2012) A. von Gise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway
- (2012) Wanjin Hong et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
- (2011) Michelangelo Cordenonsi et al. CELL
- Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin
- (2011) H. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size
- (2011) T. Heallen et al. SCIENCE
- The Hippo Signaling Pathway in Development and Cancer
- (2010) Duojia Pan DEVELOPMENTAL CELL
- The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
- (2010) H. Song et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of organ size: Insights from theDrosophilaHippo signaling pathway
- (2009) Madhuri Kango-Singh et al. DEVELOPMENTAL DYNAMICS
- A Robust Automated Measure of Average Antibody Staining in Immunohistochemistry Images
- (2009) Kingshuk Roy Choudhury et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- TEAD mediates YAP-dependent gene induction and growth control
- (2008) B. Zhao et al. GENES & DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now